TABLE 1

FLB-12 concentrations in mouse and human tumor xenograft tissues

Six- to eight-week-old C57BL/6 female and SCID/NOD mice xenografted with LS174T cells (group average flank tumor volume ∼0.45 mm3) were injected with rifampicin (50 mg · kg−1 · day−1 i.p.) and/or orally gavaged FLB-12 (300 mg · kg−1 · day−1) for 4 days. All tissues were harvested on day 4 for assessment of FLB-12 concentrations, as described under Materials and Methods.

Samples & Treatment GroupsConcentration
μM
Plasma
    FLB-1228.0 ± 3.5
    Rifampicin/FLB-1233.31 ± 1.69
Liver
    FLB-1223.45 ± 1.55
    Rifampicin/FLB-1223.1 ± 4.4
Tumor (LS174T xenografts)
    FLB-1224.5 ± 2.1
    Rifampicin/FLB-1223.475 ± 3.325